Preprint Not peer-reviewed  ·  Panacea Bio Chem Technical Preprint Series
New Results/ Synthetic Biology· Bioinformatics· Computational Protein Design
RFdiffusion de novo protein design explainer — a Panacea Bio Chem preprint by Bogdan Dicoias Panacea Bio ChemTechnical Preprint · Generative Protein Design
De Novo Protein Design · Diffusion Models · Method Review

RFdiffusion (De Novo Protein Design): how diffusion models design proteins that never existed — and the problem of making them real

Bogdan Dicoias1 — Scientist, Panacea Bio Chem

1Panacea Bio Chem Ltd, United Kingdom · correspondence via panaceabiochem.co.uk

Preprint — not peer-reviewed Posted 05 Jul 2026 Ref PBC-PP-2026-RFD Type Method review Field Generative protein design
A de novo protein backbone rendered as a rainbow ribbon — the kind of new structure RoseTTAFold Diffusion (RFdiffusion) designs from noise, a Panacea Bio Chem explainer by Bogdan Dicoias
A folded protein backbone shown as a ribbon — the class of structure RFdiffusion (RoseTTAFold Diffusion) generates from pure noise. Explainer by Panacea Bio Chem and Bogdan Dicoias.
Abstract

RFdiffusion — short for RoseTTAFold Diffusion — is a generative diffusion model5 for de novo protein design: it starts from random noise and denoises it, step by step, into a new, foldable protein backbone that corresponds to nothing in nature. Built by fine-tuning the RoseTTAFold structure-prediction network and paired with the ProteinMPNN2 sequence designer, it turns "I need a protein that does X" into a design brief a machine can answer — binders, enzymes, scaffolds and nanocages evolution never made. Yet designing a structure is only half the story. A designed, non-natural chain still has to be expressed, folded, dried, stored and reconstituted without falling apart — and that last mile, keeping a designed protein intact all the way to use, is the frontier Panacea Bio Chem works on.

Keywords: RFdiffusion · RoseTTAFold Diffusion · de novo protein design · generative protein design · diffusion model · ProteinMPNN · protein backbone generation · computational protein design

1.  Introduction — from reading proteins to writing them

Every protein is a chain of amino acids that folds into a precise three-dimensional shape, and that shape decides what the protein does. For fifty years, the central problem was reading that shape: given a sequence, what does it fold into? Deep learning answered it. Alpha folding reads the fold of proteins that already exist →; RoseTTAFold, from the Baker lab, solved the same puzzle a different way4.

But reading nature's proteins is not the same as writing our own. RoseTTAFold Diffusion — usually shortened to RFdiffusion — turns the structure-prediction engine around. Instead of reading an existing protein, it generates entirely new ones1: shapes that obey every physical rule real proteins follow, yet exist in no genome and have no evolutionary history.

The distinction matters. Nature's proteins are the survivors of four billion years of accident — a vast but arbitrary sample of what could exist. De novo design steps off that map. It asks not "what did evolution leave behind?" but "what shape would do the job — and can we build it?" That is a new kind of question, and RFdiffusion is one of the first tools that can answer it.

2.  What "RoseTTAFold Diffusion" means

The idea borrowed from image generators

RFdiffusion borrows the engine behind image-generating diffusion models5 — the same family that turns a text prompt into a picture. Those models are trained by taking real images, adding noise until they are pure static, and learning to reverse the process: static in, coherent picture out. RFdiffusion does the identical trick with protein structures. Train it to un-noise thousands of real protein backbones, and it learns the deep grammar of how a chain of amino acids is allowed to fold — then it can start from a fresh cloud of noise and denoise it into a backbone that has never existed but could. The rules are real; the protein is new.

3.  How diffusion designs a protein

The process runs backwards, from chaos to order:

  1. Start from noise — a cloud of randomly placed atoms, meaning nothing.
  2. Denoise, step by step — the model nudges that cloud over many iterations toward a plausible folded backbone.
  3. Condition on a job — "bind this target," "scaffold this active site," "form this symmetric cage." The shape is grown to do something, not merely to exist.
  4. Assign a sequence — a partner network, ProteinMPNN2, reads the finished backbone and works out which amino-acid sequence would fold into it.
  5. Test at the bench — the designed genes are expressed and the proteins checked; a meaningful fraction fold and function as intended.
For the first time, "I need a protein that grips this exact target" is a design brief you can hand to a machine — not a search through what evolution happened to leave behind.

4.  Why it matters — and where the wall is

De novo design opens doors natural proteins keep shut. But the field's centre of gravity is already shifting: the design half is getting solved faster than the make-it-real half. The table below is the fault line.

DimensionReading nature's proteinsWriting de novo proteins
Core questionWhat does this sequence fold into?What shape does the job — build it
Search spaceProteins evolution happened to makeThe unexplored protein universe
Representative toolAlphaFold · RoseTTAFoldRFdiffusion + ProteinMPNN
OutputA predicted structureA novel binder, enzyme, scaffold or cage
Stability track recordBacked by natural selectionOften marginal — must be engineered
The open bottleneckLargely solvedExpress · fold · dry · store · deliver

Novel folds can be marginally stable — easy to unpick during drying or storage. Sequences evolution never wrote fold by rules the natural-protein playbook, and natural stabilisers, only partly cover. A brilliant design that denatures in the vial is a brilliant design that never reaches anyone. Designing the structure is increasingly the easy half; keeping a designed structure intact into a usable form is the frontier.

5.  Where Panacea Bio Chem works — the preservation frontier

That frontier — designed, non-natural chains rather than evolved ones — is precisely the ground Panacea Bio Chem works on. Panacea builds custom amino-acid chains to purpose and treats the last mile — keeping a designed shape intact from the synthesiser to the syringe — as the real problem. Its ongoing work explores proprietary methods aimed at exactly the failure modes above:

The exact chemistries, sequences, parameters and hardware that make these methods repeatable remain proprietary to Panacea Bio Chem — the outline is here; the recipe stays behind the door.

Panacea Bio Chem's specific proprietary contribution to the de novo / designed-protein sphere is held by Bogdan Dicoias and is being prepared for disclosure. The exact new advance — beyond the preservation work described above — will be stated here once the operator confirms the wording. Nothing on this page invents a claim on his behalf.

6.  The first protein that never existed

De novo design has a founding moment, and it predates diffusion models by twenty years. In 2003, before deep learning touched biology, the Baker lab set the Rosetta software an audacious task: design a protein with a fold found nowhere in nature, atom by atom, and see whether real chemistry would obey the blueprint3. They iterated between choosing a sequence and predicting the structure it would make, and converged on a 93-residue α/β protein they called Top7. When it was expressed, crystallised and its structure solved, Top7 matched the design to within 1.2 ångströms — and was extraordinarily stable. A shape that had never existed had been written on a computer and then made real, exactly as drawn.

That proof-of-principle became a field. Two decades later its architect, David Baker, shared the 2024 Nobel Prize in Chemistry for computational protein design6; RFdiffusion is the generative heir of the same lineage. From Top7's single hand-guided fold to a diffusion model that dreams up backbones on demand, the arc is one long answer to a single question: if we can read the language of proteins, can we write in it? The answer is now yes — and the next sentence is about keeping what we write alive.

A computational ribbon model of a folded protein with a bound cofactor — the structural language de novo protein design and RFdiffusion write in, a Panacea Bio Chem explainer by Bogdan Dicoias
A ribbon model of a folded protein — the structural grammar that de novo protein design writes in. Explainer by Panacea Bio Chem, Bogdan Dicoias.

7.  Application fields

Designed proteins earn the most where nature left a gap — where no evolved molecule does quite what is needed:

Each of these shares one dependency the excitement often skips: the molecule has to survive synthesis, drying, storage and reconstitution still folded. That dependency is the thread tying generative design back to preservation — and to Panacea's work.

Frequently asked

What is RFdiffusion?
RFdiffusion (RoseTTAFold Diffusion) is a generative diffusion model for de novo protein design, built by fine-tuning the RoseTTAFold structure-prediction network. It starts from random noise and denoises it into a new, foldable protein backbone that exists nowhere in nature. It was described by Watson and colleagues in Nature in 2023.

How is de novo protein design different from AlphaFold?
AlphaFold and RoseTTAFold read structure — given a sequence, they predict its fold. RFdiffusion writes structure — it generates new backbones built to perform a task, then ProteinMPNN works out a sequence that folds into each one.

What can de novo designed proteins be used for?
Custom binders for disease targets, de novo enzymes, vaccine and antigen scaffolds, symmetric nanocages, biosensors and bespoke therapeutic peptides — functions reached by design rather than by what evolution happened to make.

What is the hardest part of using a designed protein?
Making it real. A designed, non-natural chain must be expressed, folded, dried, stored and reconstituted without unfolding — and novel sequences sit outside the middle that natural stabilisers handle well. Keeping a designed structure intact to the point of use is the frontier Panacea Bio Chem works on.

Trending in the field

References & further reading

  1. Watson JL, Juergens D, Bennett NR, et al. De novo design of protein structure and function with RFdiffusion. Nature 620, 1089–1100 (2023).
  2. Dauparas J, Anishchenko I, Bennett N, et al. Robust deep learning–based protein sequence design using ProteinMPNN. Science 378, 49–56 (2022).
  3. Kuhlman B, Dantas G, Ireton GC, et al. Design of a novel globular protein fold with atomic-level accuracy (Top7). Science 302, 1364–1368 (2003).
  4. Protein design — overview and history. Wikipedia.
  5. Diffusion model (generative machine learning). Wikipedia.
  6. David Baker — computational protein design and the 2024 Nobel Prize in Chemistry. Wikipedia.
  7. AlphaFold — protein structure prediction. Wikipedia.

The Panacea Technology Universe

26 technologies, each the leader of its class

Proprietary Panacea Bio Chem Ltd technologies, invented by Bogdan Dicoias — what each one does, and why it leads its class.

Lyoprester® technology convergence — the Panacea Bio Chem technologies that meet inside one cartridge, invented by Bogdan Dicoias
Lyoprester® — Panacea Bio Chem technology by Bogdan DicoiasLyoprester®The only dual-chamber cartridge that is autoreconstitution-enabled, vacuum-sealed and argon-fillback.lyoprester.com ↗P-EARLs — Panacea Bio Chem technology by Bogdan DicoiasP-EARLs™Panacea-Engineered Aseptic Reconstitution Liquid(s) — each tuned to the peptide it wakes.p-earls.com ↗Peptourbillon — Panacea Bio Chem technology by Bogdan DicoiasPeptourbillon™The layered peptide formulation architecture — single- or multi-layer, never a blend.peptourbillon.com ↗RF Tunnel — Panacea Bio Chem technology by Bogdan DicoiasRF Tunnel™The RF-formed central channel through the cake.rftunnel.com ↗TgShift — Panacea Bio Chem technology by Bogdan DicoiasTgShift™Raises the cake’s glass-transition temperature with RF — instead of chilling below it.tgshift.com ↗Cryolapse — Panacea Bio Chem technology by Bogdan DicoiasCryolapse™Cryogenic pressure collapse under S3Pulse™ control — vapour redistributed through the whole cake, not its surface, impeding crust formation.cryolapse.com ↗LyoLevit — Panacea Bio Chem technology by Bogdan DicoiasLyoLevit™The cake levitates and spins in high orbit — driven by ultrasound and RF.lyolevit.com ↗Lyochrysalis — Panacea Bio Chem technology by Bogdan DicoiasLyochrysalis™The integrated chamber housing the whole drying stack.lyochrysalis.com ↗S3Pulse — Panacea Bio Chem technology by Bogdan DicoiasS3Pulse™The control brain for every piece of Panacea hardware.s3pulse.com ↗Liquiprester — Panacea Bio Chem technology by Bogdan DicoiasLiquiprester™The single-liquid cartridge engineered so multiple peptide APIs coexist in one shared vehicle.liquiprester.com ↗Syntheseract — Panacea Bio Chem technology by Bogdan DicoiasSyntheseract™Continuous-flow peptide synthesis in a special, very fast and economical way.syntheseract.com ↗CFSPPS — Panacea Bio Chem technology by Bogdan DicoiasCFSPPS™Continuous-flow solid-phase peptide synthesis, written as its own category.cfspps.com ↗OxyDeplete — Panacea Bio Chem technology by Bogdan DicoiasOxyDeplete™Degassing plus no-headspace doctrine — the oxygen-starved seal.oxydeplete.com ↗ArgonLock — Panacea Bio Chem technology by Bogdan DicoiasArgonLock™The final inert-atmosphere lock under argon.argonlock.com ↗RedoxVault — Panacea Bio Chem technology by Bogdan DicoiasRedoxVault™Separation, not merely suppression — redox isolation in lipid micro-reservoirs.redoxvault.com ↗PleniDose — Panacea Bio Chem technology by Bogdan DicoiasPleniDose™The shared filling gantry — one machine filling both the dual-chamber Lyoprester and the liquid Liquiprester.plenidose.com ↗IncreSure — Panacea Bio Chem technology by Bogdan DicoiasIncreSure™The dose-metrology layer — verified API per pen increment.incresure.com ↗ElimiVoid — Panacea Bio Chem technology by Bogdan DicoiasElimiVoid™Front-void elimination without touching the metered dose.elimivoid.com ↗Cryoviscous — Panacea Bio Chem technology by Bogdan DicoiasCryoviscous™The characterised cold, high-viscosity, low-mobility conditioning state.cryoviscous.com ↗Vana Machine — Panacea Bio Chem technology by Bogdan DicoiasVana Machine™Vacuum–Argon–Nitrogen Architecture — draws the air and nitrogen out of the cake and backfills with argon; in a separate process, the same machine makes the P-EARLs bubble-free.www.vanamachine.com ↗EZnject — Panacea Bio Chem technology by Bogdan DicoiasEZnject™The disposable auto-injector pen built around the Lyoprester.panaceaeznject.com ↗Dicoias Ψ — Panacea Bio Chem technology by Bogdan DicoiasDicoias ΨThe computed-chemistry advisory — every substance reduced to a vector across physical, electronic and formulation space.dcppsi.com ↗SealoPrester — Panacea Bio Chem technology by Bogdan DicoiasSealoPrester™Aseptic Cartridge Closure System — Seal o’ Precision + Sterility.sealoprester.com ↗Peptidic Liquid — Panacea Bio Chem technology by Bogdan DicoiasPeptidic LiquidThe peptide formulation in solution — the active plus its buffers, cryoprotectants, lyoprotectants and scaffolders.peptidicliquid.com ↗DiastolVAC — Panacea Bio Chem technology by Bogdan DicoiasDiastolVAC™Biomimetic diastolic vacuum control — the pneumatic circulatory system of the machine: pumps, valves and sensors as one ensemble.diastolvac.com ↗KineticON — Panacea Bio Chem technology by Bogdan DicoiasKineticON™Motion Integrity Architecture — the motion-control layer that lets the machine know what happened on every axis move.kineticon.org ↗

Weekly review — 28 Sep – 4 Oct 2026

Publications indexed in PubMed in the last 30 days for de novo protein design diffusion OR RFdiffusion protein — refreshed weekly.